Home › Funds › Marex Group Ltd › HIMS

Marex Group Ltd position in HIMS

HIMS & HERS HEALTH INC · Health Care

Marex Group Ltd reported holding 973,771 shares of HIMS (HIMS & HERS HEALTH INC) in its Q2 2026 13F filing — a position valued at US$33.8M, representing 0.43% of its reported portfolio and ranking #49 among its reported holdings. Marex Group Ltd has disclosed HIMS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)973.77K sh
Reported value held$33.76M
Portfolio Weight0.43%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Marex Group Ltd's HIMS position evolved

Marex Group Ltd first disclosed a stake in HIMS in Q2 2024 at 105,000 shares (US$2.1M). The position peaked in Q4 2025 at 2,419,518 shares, worth US$78.6M. Across 9 filings, Marex Group Ltd increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 973,771 shares valued at US$33.8M — a reduction of -365,043 shares quarter over quarter.. Notable position changes include a 2543% increase in Q1 2025 (shares rose 69% over the following quarter), a 233% increase in Q2 2025 (shares rose 14% over the following quarter), a 162% increase in Q4 2025 (shares fell 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 105.00K $2.12M New
Q3 2024 105.91K $1.95M Add
Q4 2024 12.29K $297.12K Reduce
Q1 2025 324.75K $9.60M Add
Q2 2025 1.08M $53.63M Add
Q3 2025 922.81K $52.34M Reduce
Q4 2025 2.42M $78.56M Add
Q1 2026 1.34M $27.79M Reduce
Q2 2026 973.77K $33.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HIMS and 13F data

HIMS (HIMS & HERS HEALTH INC) is a Health Care company. 34 other funds we track also report a position in HIMS — the largest reported positions include Divisadero Street Capital Management, LP (US$208.3M), Bienville Capital Management, LLC (US$27.2M), Foresite Capital Management V, LLC (US$25.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HIMS

All HIMS fund holders →

FAQ

How long has Marex Group Ltd held HIMS?

Marex Group Ltd has disclosed HIMS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Marex Group Ltd's current position in HIMS?

As of Q2 2026, Marex Group Ltd holds 973.77K shares of HIMS (HIMS & HERS HEALTH INC), valued at $33.76M, representing 0.43% of its reported portfolio and ranking #49.

Has Marex Group Ltd been buying or selling HIMS?

In the latest 13F filing (Q2 2026), Marex Group Ltd reduced its position in HIMS. The position peaked in Q4 2025 at 2.42M shares.

Which other funds hold HIMS?

Other major institutional holders of HIMS include Divisadero Street Capital Management, LP, Bienville Capital Management, LLC, Foresite Capital Management V, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.